Trial
NCT01194856
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID); Case Western Reserve University; Bristol-Myers Squibb
Condition
HIV Infection
Intervention
Atazanavir/ritonavir
Why stopped
Closed due to low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-11